Astrasana Holding AG has established a pharmaceutical joint venture in the Czech Republic, creating a dedicated entity for the import and distribution of medical cannabis products in one of Central Europe’s most advanced cannabis markets.
Astrasana Pharma s.r.o., the newly formed company, holds a SUKL licence for pharmaceutical distribution and is authorised to import and distribute medical cannabis products throughout the Czech Republic.
Czech Cannabis Market
The Czech Republic has maintained a legal framework for medical cannabis since 2013, making it one of the earliest adopters in Europe. The market has shown consistent growth, driven by:
- Increasing physician awareness and prescribing confidence
- Expanding insurance coverage for cannabis-based therapies
- Progressive regulatory updates improving patient access
- A well-established pharmacy distribution infrastructure
Operational Capabilities
Astrasana Pharma s.r.o. operates from the company’s logistics centre in Prague, providing:
- SUKL-compliant pharmaceutical warehousing
- Temperature-controlled storage for cannabis products
- Nationwide distribution to licensed pharmacies
- Full batch traceability and quality documentation
The Czech Republic joins Switzerland as a core market for Astrasana’s pharmaceutical distribution operations, with plans to leverage this presence for expansion into neighbouring Central European markets.
